Skip header and navigation

Refine By

156 records – page 1 of 16.

[113 cases of cancer. A 10-year case material from general practice]

https://arctichealth.org/en/permalink/ahliterature26767
Source
Tidsskr Nor Laegeforen. 1984 May 10;104(13):886-90
Publication Type
Article
Date
May-10-1984
Author
M. Nylenna
Source
Tidsskr Nor Laegeforen. 1984 May 10;104(13):886-90
Date
May-10-1984
Language
Norwegian
Publication Type
Article
Keywords
Adult
Aged
Female
Humans
Male
Middle Aged
Neoplasms - diagnosis - therapy
Norway
Physicians, Family
Terminal Care
PubMed ID
6463977 View in PubMed
Less detail

Accuracy of tele-oncology compared with face-to-face consultation in head and neck cancer case conferences.

https://arctichealth.org/en/permalink/ahliterature19396
Source
J Telemed Telecare. 2001;7(6):338-43
Publication Type
Article
Date
2001
Author
J. Stalfors
S. Edström
T. Björk-Eriksson
C. Mercke
J. Nyman
T. Westin
Author Affiliation
Department of Otolaryngology, Head and Neck Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden. joacim.stalfors@orlforum.com
Source
J Telemed Telecare. 2001;7(6):338-43
Date
2001
Language
English
Publication Type
Article
Keywords
Aged
Aged, 80 and over
Case Management - organization & administration
Feasibility Studies
Female
Head and Neck Neoplasms - diagnosis - therapy
Humans
Male
Middle Aged
Physical Examination
Remote Consultation
Research Support, Non-U.S. Gov't
Telemedicine - methods
Abstract
Telemedicine was introduced for weekly tumour case conferences between Sahlgrenska University Hospital and two district hospitals in Sweden. The accuracy of tele-oncology was determined using simulated telemedicine consultations, in which all the material relating to each case was presented but without the patient in person. The people attending the conference were asked to determine the tumour ('TNM') classification and treatment. The patient was then presented in person, to give the audience the opportunity to ask questions and perform a physical examination. Then a new discussion regarding the tumour classification and the treatment plan took place, and the consensus was recorded. Of the 98 consecutive patients studied in this way, 80 could be evaluated by both techniques. Of these 80, 73 (91%) had the same classification and treatment plan in the telemedicine simulation as in the subsequent face-to-face consultation. In four cases the TNM classification was changed and for three patients the treatment plan was altered. The specialists also had to state their degree of confidence in the tele-oncology decisions. When they recorded uncertainty about their decision, it was generally because they wanted to palpate the tumour. In five of the seven patients with a different outcome, the clinical evaluation was stated to be dubious or not possible. The results show that telemedicine can be used safely for the management of head and neck cancers.
PubMed ID
11747635 View in PubMed
Less detail

[An automated computer system for the differential diagnosis and laser treatment of benign neoplasms and tumor-like masses in the oral cavity].

https://arctichealth.org/en/permalink/ahliterature205280
Source
Stomatologiia (Mosk). 1998;77(3):61-5
Publication Type
Article
Date
1998
Author
N A Zhizhina
A A Prokhonchukov
V F Ermolov
V Iu Pelkovskii
Source
Stomatologiia (Mosk). 1998;77(3):61-5
Date
1998
Language
Russian
Publication Type
Article
Keywords
Computer Systems
Diagnosis, Computer-Assisted - methods
Diagnosis, Differential
Expert Systems
Humans
Laser Therapy - methods
Mouth Neoplasms - diagnosis - therapy
Russia
Abstract
Automated computer system for differential diagnosis and defining the indications for pathogenetic therapy is described, which was used in 2816 patients and was effective in 97% of cases. The system includes computer-regulated Lancet surgical lasers (wavelength 10.6 microns, power 60 W, frequency 0.05-1.0 Hz) and Optodan physiotherapeutic laser (wavelength 0.85 micron, power 4 W, frequency 0.08-3 kHz).
PubMed ID
9643118 View in PubMed
Less detail

[A visit to the "Radiumhemmet" of Stockholm. Positive results in the struggle against tumors]

https://arctichealth.org/en/permalink/ahliterature28781
Source
Minerva Med. 1966 Nov 10;57(90):varia 1452+
Publication Type
Article
Date
Nov-10-1966
Author
V. Fabbrocini
Source
Minerva Med. 1966 Nov 10;57(90):varia 1452+
Date
Nov-10-1966
Language
Italian
Publication Type
Article
Keywords
Humans
Neoplasms - diagnosis - therapy
Sweden
PubMed ID
5957085 View in PubMed
Less detail

Basal cell carcinoma--new aspects of diagnosis and treatment.

https://arctichealth.org/en/permalink/ahliterature20361
Source
Acta Derm Venereol Suppl (Stockh). 2000;209:5-25
Publication Type
Article
Date
2000
Author
A M Wennberg
Author Affiliation
Department of Dermatology, Sahlgrenska University Hospital, Göteborg University.
Source
Acta Derm Venereol Suppl (Stockh). 2000;209:5-25
Date
2000
Language
English
Publication Type
Article
Keywords
Aminolevulinic Acid - pharmacokinetics - therapeutic use
Carcinoma, Basal Cell - diagnosis - therapy
Humans
Interferons - therapeutic use
Laser-Doppler Flowmetry
Microdialysis
Mohs Surgery
Photochemotherapy
Photosensitizing Agents - pharmacokinetics - therapeutic use
Research Support, Non-U.S. Gov't
Skin Neoplasms - diagnosis - therapy
Spectrometry, Fluorescence
Abstract
The incidence of basal cell carcinoma is increasing. New aspects of diagnosis and treatment are discussed in this thesis. Interferon can be used for the treatment of BCC. In paper I, 15 patients received 13.5 x 10(6) IU of alfa-2b-interferon intralesionally. Four patients healed completely whereas a 75% reduction was seen in 5 cases. Intralesional alfa-2b-interferon can reduce the number of excisions during Mohs Micrographic Surgery. Topical photodynamic therapy involves the application of ALA on the skin. In tumour cells selectively, formation of the photosensitizer Pp IX occurs. After 4 hours of occlusion of ALA the area is irradiated with light at a wavelength of 630 nm. Tumour cells are selectively destroyed during this procedure. 144/157 SBCC healed in this series and 14/18 Mb Bowen (paper II). The method is only suited for thin BCCs as the result on thicker lesions is poor (2/10 healed). The cosmetic result was generally good or excellent. Another way of utilising the tumour selectivity of Pp IX is for diagnostic purposes. Instead of illuminating with 630 nm, 365, 366 and 405 nm are used to induce a specific fluorescence. In the present paper (III), 50% of facial BCCs with ill-defined borders could be completely visualised and another 23% partly outlined. The technique did not seem to work in 27% of the cases. The critical factor using ALA is probably the relatively poor penetrance through the skin. In paper IV, microdialysis is used for pharmacokinetic studies of ALA for the first time. The concentration of ALA increases rapidly in lesional skin whereas there is virtually no penetration in healthy skin. Also, the blood perfusion in BCCs was investigated by means of laser Doppler Perfusion Imager. The perfusion in skin overlying a BCC was 2.5 fold higher compared to normal skin. For BCCs with ill-defined borders Mohs Micrographic Surgery is generally recommended. Regarding Mohs Micrographic Surgery, Sweden is underserved as only 1% of BCCs are treated with Mohs Micrographic Surgery as opposed to 30% in the US. Consequently, the Swedish cases are probably more severe. The long-term results are reported in paper V. Two hundred and twenty-eight tumours were followed for at least 5 years. The rate of recurrence was 8%. This figure is slightly higher than in international materials but surprisingly low considering the type of tumours.
PubMed ID
10884941 View in PubMed
Less detail
Source
Med Oncol. 1997 Sep-Dec;14(3-4):141-3
Publication Type
Article
Author
S. Hellsten
G. Steineck
Author Affiliation
Department of Urology, Malmoe University Hospital, Malmö, Sweden.
Source
Med Oncol. 1997 Sep-Dec;14(3-4):141-3
Language
English
Publication Type
Article
Keywords
Bladder Neoplasms - diagnosis - therapy
Humans
Sweden
Abstract
The survival of patients with bladder cancer has not improved significantly during the past decades in spite of new diagnostic methods and treatment modalities. This observation underlines the need for improved routines to ensure earlier detection of the disease by patients and doctors and thereby start the treatment sooner. The common finding of treatment failures in patients who have shown no sign of local recurrence but have undergone radical cystectomy indicates that subclinical metastases are primarily responsible for the poor outcome in most cases. This indicates that, in addition to radical surgery, effective chemotherapy is needed to counteract the systemic spread of the disease.
PubMed ID
9468036 View in PubMed
Less detail

A brain cancer pathway in clinical practice.

https://arctichealth.org/en/permalink/ahliterature124769
Source
Dan Med J. 2012 May;59(5):A4437
Publication Type
Article
Date
May-2012
Author
Emilie Lund Laursen
Birthe Krogh Rasmussen
Author Affiliation
Department of Neurology, Hillerød Hospital, Hillerød, Denmark. emilielundlaursen@hotmail.com
Source
Dan Med J. 2012 May;59(5):A4437
Date
May-2012
Language
English
Publication Type
Article
Keywords
Adult
Aged
Aged, 80 and over
Brain Neoplasms - diagnosis - therapy
Critical Pathways
Denmark
Early Detection of Cancer
Female
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Predictive value of tests
Referral and Consultation
Retrospective Studies
Sensitivity and specificity
Abstract
Danish healthcare seeks to improve cancer survival through improved diagnostics, rapid treatment and increased focus on cancer prevention and early help-seeking. In neuro-oncology, this has resulted in the Integrated Brain Cancer Pathway (IBCP). The paper explores how the pathway works in the initial phase in a clinical setting with emphasis on pathway criteria.
All patients admitted during the first two-year period to a regional neurology department in Denmark and fulfilling the IBCP inclusion criteria were included. Data regarding onset symptoms, diagnosis and time for diagnostic work-up were obtained and supplemented by a retrospective review of patient records. Sensitivities, specificities and positive predictive values of the inclusion criteria were calculated with magnetic resonance imaging scan of the cerebrum as index of validity.
The strength of the pathway inclusion criteria was determined largely by the number of criteria fulfilled and by the type of predominant symptoms. The criteria identified the majority of patients with symptomatic brain malignancy and were also highly predictive of general structural brain lesions.
The introduction of the pathway is a major step forward in the efforts to optimize brain cancer patients' illness trajectory.
This study was funded by a grant from the Danish Ministry of Health and Interior Affairs 2009 and the Helen Rude Foundation and has been approved by the Danish Data Protection Agency.
not relevant.
PubMed ID
22549490 View in PubMed
Less detail
Source
CMAJ. 1998 May 5;158(9):1131; author reply 1132
Publication Type
Article
Date
May-5-1998
Author
L. Mahoney
Source
CMAJ. 1998 May 5;158(9):1131; author reply 1132
Date
May-5-1998
Language
English
Publication Type
Article
Keywords
Adult
Breast Neoplasms - diagnosis - therapy
Canada
Female
Humans
Middle Aged
Practice Guidelines as Topic
Notes
Comment On: CMAJ. 1998 Feb 10;158 Suppl 3:S3-89484272
PubMed ID
9597960 View in PubMed
Less detail

Canadian guidelines for retinoblastoma care.

https://arctichealth.org/en/permalink/ahliterature146551
Source
Can J Ophthalmol. 2009 Dec;44(6):639-42
Publication Type
Article
Date
Dec-2009
Author
Brenda Gallie
Source
Can J Ophthalmol. 2009 Dec;44(6):639-42
Date
Dec-2009
Language
English
French
Publication Type
Article
Keywords
Canada
Humans
Practice Guidelines as Topic
Retinal Neoplasms - diagnosis - therapy
Retinoblastoma - diagnosis - therapy
PubMed ID
20029477 View in PubMed
Less detail

[Cancer packages: Does haste lead to more work?].

https://arctichealth.org/en/permalink/ahliterature123625
Source
Ugeskr Laeger. 2012 Jun 11;174(24):1657
Publication Type
Article
Date
Jun-11-2012
Author
Michael Kosteljanetz
Source
Ugeskr Laeger. 2012 Jun 11;174(24):1657
Date
Jun-11-2012
Language
Danish
Publication Type
Article
Keywords
Denmark
Humans
Neoplasms - diagnosis - therapy
Practice Guidelines as Topic
Time Factors
Notes
Comment In: Ugeskr Laeger. 2012 Sep 10;174(37):2183; author reply 218023136645
PubMed ID
22681988 View in PubMed
Less detail

156 records – page 1 of 16.